MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
PR Newswire

News of the day

Apieron Alleges Evidence Shows Aerocrine Inventors Withheld Prior Art Information from Patent Office

18th November 2009 MENLO PARK, California, November 18 /PRNewswire/ -- Apieron, Inc. has asked the court presiding over its patent suit against Aerocrine, Inc. to allow it to raise additional grounds for invalidating Aerocrine's broadest patent relating to exhaled nitric oxide, U.S. Patent No. 5,922,610. In its motion, Apieron alleges that recently obtained deposition testimony and interrogatory responses indicate that Drs. Kjell Alving, Jan Lundberg, and Edward Weitzberg, inventors named on the '610 patent,... more

NeuroTherm is Awarded US Patent for Multi-lesion Radiofrequency Generator

23rd September 2009 WILMINGTON, Massachusetts, September 23 /PRNewswire/ -- NeuroTherm is pleased to be recognized by the United States Patent Office as the first company worldwide to develop and release a multiple output radiofrequency generator used in the treatment of chronic pain, ref. US Patent No. 7,574,257. more

Apieron, Inc. Files Infringement Complaint Against Aerocrine AB, Aerocrine AG and Mr. Magnus Pelles

16th July 2009 MENLO PARK, California, July 16 /PRNewswire/ -- Today, Apieron, Inc. (http://www.apieron.com/) reported that it filed a patent infringement complaint against Aerocrine AB, Solna, Sweden, Aerocrine AG, Bad Homburg, Germany and Mr. Magnus Pelles, Usingen, Germany in the Regional Court of Mannheim, Germany. Apieron, makers of the Insight(TM) eNO System for measurement of exhaled nitric oxide, presented this complaint against Aerocrine on the grounds that they are offering and putting on the market... more
Patent Law RSS feed

PR Newswire search

Search the PR Newswire by keyword. Alternatively our advanced search allows you to query by category.
 

Category

To choose more then one item on the list hold CTRL button while selecting. To deselect items press CTRL button and deselect.

Browse by category

More recent news

UK Court of Appeal Rules in Smith & Nephew's Favour
14th July 2009 HULL, England, July 14 /PRNewswire/ -- Smith & Nephew's Advanced Wound Management division (LSE: SN) (NYSE: SNN) announced that the UK Court of Appeal has ruled as invalid all claims asserted...

Raptor Pharmaceuticals Receives Notices of Allowance for Two NeuroTrans(TM) Patent Applications
29th April 2009 NOVATO, California, April 29 /PRNewswire/ -- Raptor Pharmaceuticals Corp. ("Raptor" or the "Company") (OTC Bulletin Board: RPTP) today announced that the United States Patent and Trademark Office...

GDFII/L&P Sucralose Win Over Competitor Tate & Lyle
7th April 2009 EXETER, California, April 7 /PRNewswire/ -- Leading Sucralose manufacturer Guangdong Food Industry Institute/L&P Food Ingredient Co. Ltd. (GDFII/L&P) today announced that the U.S....

Shire Files Lawsuit Against Mylan for Infringement of FOSRENOL(R) (Lanthanum Carbonate) Patent
20th March 2009 PHILADELPHIA, Pennsylvania and DUBLIN, Ireland, March 20 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY) announces that it has filed a lawsuit in the U.S. District Court of the Southern District...

InNexus Biotechnology Announces New Patents Protecting Novel Cell Penetrating DXL(TM) Antibodies
6th March 2009 BRITISH COLUMBIA, Canada, March 6 /PRNewswire/ -- InNexus Biotechnology Inc. (OTC Bulletin Board: IXSBF; TSX VENTURE: IXS; http://www.ixsbio.com), a drug development company commercializing the next...

Motorcycle Cancer Risk: Motorcycle Cop Cancer Concern from ELF EMFs Penetrating Motorcycle Seats
3rd March 2009 MISSISSAUGA, Ontario, March 3 /PRNewswire/ -- A book entitled Motorcycle Cancer? is sending a shock wave through the motorcycle industry worldwide. "Motorcycle seat extremely low...

Mindset BioPharmaceuticals (USA) Inc Obtains Notice of Allowance for European Patent Related to Use of Insulin Sensitizers in Senile Dementia, Dementia and Memory Loss
24th February 2009 NEW YORK, February 24 /PRNewswire/ -- Mindset BioPharmaceuticals (USA) Inc ("MINDSET") a company privately held by MPM Capital and other shareholders announced today that it has received a Notice of...

AGA Medical Corporation Begins Proceedings Against Occlutech to Recover Damages
29th January 2009 MINNEAPOLIS, January 29 /PRNewswire/ -- AGA Medical Corporation (AGA) today announced that, following its previously announced favorable patent infringement final ruling by the German court of...

Neuralstem Receives Final Notice of Allowance for New Stem Cell Immortalization Technology Patent
26th January 2009 ROCKVILLE, Maryland, January 26 /PRNewswire/ -- Neuralstem, Inc. (NYSE Alternext US: CUR) today announced that it has received Official Notice of Allowance for its patent application,...

Bavarian Nordic's Case Against Oxford BioMedica
12th January 2009 KVISTGARD, Denmark, January 12 /PRNewswire/ -- Bavarian Nordic owns several United States patents relating to an attenuated strain of the company's core technology, MVA-BN(R), which is the basis for...

German Appeals Court Rules in Favor of AGA Medical in Patent Infringement Lawsuit Against Occlutech
6th January 2009 MINNEAPOLIS, January 6 /PRNewswire/ -- AGA Medical Holdings, Inc. ("AGA Medical" or "AGA") announced today that a German appeals court has ruled in its favor in a patent infringement proceeding...

Enigma Diagnostics Announces a Signed Term Sheet for Patent Licenses with Roche Molecular Systems, Inc.
16th December 2008 PORTON DOWN, England and SAN FRANCISCO, December 16 /PRNewswire/ -- Enigma Diagnostics Limited, the decentralized and point-of-care molecular diagnostics company, announced today that it has signed a...

Stem Cell Sciences Reinforces its International Patent Position in Stem Cell Technologies
14th November 2008 CAMBRIDGE, England, November 14 /PRNewswire/ -- IRES Patent Upheld in Appeal Hearing at the EPO Stem Cell Sciences plc (AIM:STEM, ASX:STC) announces that European patent no. 0695361 covering its...

AGA Medical to Appeal Ruling by Dutch Court in Lawsuit With Occlutech GmbH
30th October 2008 MINNEAPOLIS, October 30 /PRNewswire/ -- AGA Medical Holdings ("AGA Medical", "AGA") announced today its determination to appeal a recent ruling from The Patent Court in the Netherlands related to a...

InNexus Biotechnology Receives Patent Grants in Europe
30th October 2008 BRITISH COLUMBIA, Canada, October 30 /PRNewswire/ -- InNexus Biotechnology Inc., (OTC Bulletin Board: IXSBF; TSX VENTURE: IXS; http://www.ixsbio.com), a drug development company commercializing the...

Media Statement From Servier: High Court of Justice Judgment
9th October 2008 SLOUGH, England, October 9 /PRNewswire/ -- Servier is disappointed by the decision of the English High Court (Mr Justice Norris) to award damages to Apotex of GBP17.5 million in the case of Les...

CPA Acquires Renowned German Patent Research Specialist, SVPG
8th October 2008 LONDON, October 8 /PRNewswire/ -- CPA, the world's top intellectual-property management specialist and a leading provider of outsourced legal support services, announced today that it has acquired...

Clients in focus...

Get the Flash Player to see this rotator.

Partnering and licensing intelligence in life sciences industry
BioPartnering America
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us